LIVE 2021 [THE DEFINITIVE GUIDE TO RBQM FOR EXPERTS AND BEGINNERS] On May 20-21, 2021, experts from across the industry gathered to review the current status of RBQM and its adoption by Sponsors and CROs. Missed it? Don't worry, all the sessions are available to watch on-demand. Watch #rbqmlive on-demand
The Virtual Event of '21

The adoption of Risk-Based Quality Management, the process of identifying, monitoring, and mitigating the risks that could impact the quality or safety of a clinical trial, is accelerating. Organizations are benefitting from reduced study timelines, increased efficiency, and enhanced patient safety. Join us on May 20-21, 2021 to discuss how we can continue to leverage RBQM to build safer, more efficient clinical trials of the future.

Until the day of

the event…

Meet the Speakers

Ken Getz

[Professor, Tufts Center for the Study of Drug Development]

Lynne Cesario

[Global Risk-Based Monitoring Program Lead, Pfizer]

Sy Pretorius

[President, Clinical Development and Chief Medical Officer, Parexel]

Jacqueline Gough

[Jacqueline Gough, Director, Central Monitoring, Alexion Pharmaceuticals]

Esther Huffman O’Keefe

[Associate Director - Monitoring, Regeneron Pharmaceuticals]

Mary Arnould

[Director, Astellas Pharma]